Literature DB >> 1915754

Leishmania donovani: use of two different, commercially available, chemically defined media for the continuous in vitro cultivation of promastigotes.

C McCarthy-Burke1, P A Bates, D M Dwyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1915754     DOI： 10.1016/0014-4894(91)90112-a

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN： 0014-4894            Impact factor:   2.011


× No keyword cloud information.
  14 in total

1.  A new experimental in vitro culture medium for cultivation of Leishmania species.

Authors:  M E Limoncu; I C Balcioğlu; K Yereli; Y Ozbel; A Ozbilgin
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Episomally driven antisense mRNA abrogates the hyperinducible expression and function of a unique cell surface class I nuclease in the primitive trypanosomatid parasite, Crithidia luciliae.

Authors:  Mat Yamage; Manju B Joshi; Dennis M Dwyer
Journal:  J Mol Biol       Date:  2007-08-21       Impact factor: 5.469

3.  Oral azithromycin versus its combination with miltefosine for the treatment of experimental Old World cutaneous leishmaniasis.

Authors:  Eglal I Amer; Maha M Eissa; Shereen F Mossallam
Journal:  J Parasit Dis       Date:  2014-08-31

4.  Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs.

Authors:  Martina Maritati; Alessandro Trentini; Gregory Michel; Tiziana Bellini; Shawgi Almugadam; Stefania Hanau; Marcello Govoni; Pierre Marty; Carlo Contini
Journal:  Infection       Date:  2018-08-10       Impact factor: 3.553

5.  Molecular fingerprinting of Leishmania infantum strains following an outbreak of visceral leishmaniasis in central Israel.

Authors:  Abedelmajeed Nasereddin; Gad Baneth; Gabriele Schönian; Moein Kanaan; Charles L Jaffe
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

6.  A unique, highly conserved secretory invertase is differentially expressed by promastigote developmental forms of all species of the human pathogen, Leishmania.

Authors:  Todd A Lyda; Manju B Joshi; John F Andersen; Andrew Y Kelada; Joshua P Owings; Paul A Bates; Dennis M Dwyer
Journal:  Mol Cell Biochem       Date:  2015-03-13       Impact factor: 3.396

Review 7.  Recombinant protein expression in Leishmania tarentolae.

Authors:  Giancarlo Basile; Manuela Peticca
Journal:  Mol Biotechnol       Date:  2009-11       Impact factor: 2.695

Review 8.  Cultivation of clinically significant hemoflagellates.

Authors:  Frederick L Schuster; James J Sullivan
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  NAD(P)H cytochrome b5 oxidoreductase deficiency in Leishmania major results in impaired linoleate synthesis followed by increased oxidative stress and cell death.

Authors:  Supratim Mukherjee; Sumit Sen Santara; Shantanabha Das; Moumita Bose; Jayasree Roy; Subrata Adak
Journal:  J Biol Chem       Date:  2012-08-25       Impact factor: 5.157

10.  Extracellular release of the surface metalloprotease, gp63, from Leishmania and insect trypanosomatids.

Authors:  Charles L Jaffe; Dennis M Dwyer
Journal:  Parasitol Res       Date:  2003-08-16       Impact factor: 2.289
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.